U.S. Markets closed

Merck & Co., Inc. (MRK)


NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
65.54-0.38 (-0.58%)
At close: 4:00PM EDT

65.60 0.06 (0.09%)
After hours: 5:14PM EDT

People also watch
PFEJNJBMYLLYPG
Full screen
Previous Close65.92
Open66.27
Bid65.54 x 100
Ask65.60 x 100
Day's Range65.54 - 66.27
52 Week Range55.11 - 66.80
Volume8,112,588
Avg. Volume8,994,340
Market Cap179.26B
Beta0.97
PE Ratio (TTM)41.77
EPS (TTM)1.57
Earnings DateJul 28, 2017
Dividend & Yield1.88 (2.84%)
Ex-Dividend Date2017-06-13
1y Target Est69.35
Trade prices are not sourced from all markets
  • Reuters11 minutes ago

    'GoldenEye' cyber attack goes global, exploits known code flaws

    MOSCOW/KIEV/WASHINGTON, June 27 (Reuters) - A major global cyber attack dubbed "GoldenEye" or "Petya" on Tuesday disrupted computers at Russia's biggest oil company, Ukrainian banks and multinational firms with a virus similar to the ransomware virus that last month infected more than 300,000 computers. The attack underscores growing concerns that businesses have failed to secure their networks from increasingly aggressive hackers, who have shown they are capable of shutting down critical infrastructure and crippling corporate and government networks.

  • Barrons.com1 hour ago

    [$$] Merck Cholesterol Drug Could Help Unlock Value

    In the last decade, no fewer than three major pharmaceutical companies have suffered defeat trying to bring a new class of cholesterol-lowering medication to market.s Much to the surprise of investors, Merck & Co. (MRK) could succeed where Pfizer (PFE), Roche (RHHBY) and Eli Lilly & Co. (LLY) have all failed. Merck has yet to decide if it will seek Food and Drug Administration approval, a sign to some that the company isn’t sure if the study data, though positive, are strong enough to ensure regulatory approval. Thanks to the growing success of Merck’s immunotherapy cancer drug Keytruda, the shares have gained 19% in the past year to near a 52-week high of $66.80.

  • The Wall Street Journal2 hours ago

    [$$] Cyberattacks Hit Major Companies Across Globe

    Global businesses, including Merck, Maersk and Rosneft, reported significant cyberattacks against their computer systems that expert said was ransomware.